OPTImal PHARMacological Therapy for Patients With Heart Failure: The OPTIPHARM-HF Registry

Summary

Prospective, observational, multicenter, national study of adult patients with HF to assess prescription and adherence to evidence-based Guideline-Directed Medical Therapy (GDMT) in patients with Heart Failure (HF).

Conditions

• Heart Failure

Sponsors & Collaborators

• Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy

  collaborator OTHER_GOV

• Centro Cardiologico Monzino

  collaborator OTHER

• A.O. Ospedale Papa Giovanni XXIII

  collaborator OTHER

• IRCCS Ospedale San Raffaele

  collaborator OTHER

• Azienda Ospedaliera Universitaria Senese

  collaborator OTHER

• IRCCS Humanitas, Rozzano

  collaborator UNKNOWN

• Ospedale Policlinico San Martino

  collaborator OTHER

• Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

  collaborator OTHER

• Fondazione IRCCS Policlinico San Matteo di Pavia

  collaborator OTHER

• Ospedali Riuniti di Foggia

  collaborator OTHER

• A.O.U. Città della Salute e della Scienza

  collaborator OTHER

• ASU Giuliano Isontina, Trieste

  collaborator UNKNOWN

• Azienda Ospedaliera S. Maria della Misericordia

  collaborator OTHER

• IRCCS Policlinico S. Donato

  collaborator OTHER

• ASST Santi Paolo e Carlo

  collaborator OTHER

• Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

  lead OTHER

Principal Investigators

• Marco Metra, MD · ASST Spedali Civili

• Riccardo M. Inciardi, MD, PhD · ASST Spedali Civili

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2022-07-18

Primary Completion

2024-10-01

Completion

2025-10-01

Countries

• Italy

Study Locations